drugset / Trial / NCT00560079
Efficacy of Allopurinol and Dypiridamole in Acute Mania
Phase 4
Completed
180 enrolled
Hospital Espirita de Porto Alegre
Stanley Medical Research Institute · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to evaluate the potential antimanic efficacy, safety and tolorability of the purinergic agents allopurinol and dipyridamole as an add-on treatment to lithium in a sample of 180 drug-free manic patients enrolled in a double-blind, placebo-controlled design.
Timeline
- Start
- 2003-11
- Primary completion
- 2005-04
- Completion
- 2006-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Allopurinol | Small molecule | 600 mg | Oral |
| Comparator | Dipyridamole | Other / unclassified | 200 mg | Oral |